Inhibiting the MNK-eIF4E-β-catenin axis increases the responsiveness of aggressive breast cancer cells to chemotherapyZhiqiang Li(Jiangxi University of Traditional Chinese Medicine), Peng Zhang(Jilin University)OncotargetDecember 1, 201610.18632/oncotarget.13772Cited by 43SaveCiteExport RISWatch citationsRelated PapersContribution of p62/SQSTM1 to PDGF-BB-induced myofibroblast-like phenotypic transition in vascular smooth muscle cells lacking Smpd1 gene|Cell Death and Disease|2018|33